Novartis.com | Contact Us | Help | Site Map | Stay Connected | Large Text VersionRegular Text Version

Welcome to Novartis Oncology - The Global Site

 

 

 

Novartis Oncology Media

Media

This content is intended for non-U.S. journalists. U.S. journalists, please visit the U.S. Media Room

Products

  • AFINITOR® (everolimus)
  • EXJADE® (Deferasirox)
  • Femara® (Letrozole)
  • Glivec® (Imatinib)
  • Sandostatin® LAR® (Octreotide)
  • Tasigna® (Nilotinib)
  • ZOMETA® (Zoledronic Acid)
 

ABOUT NOVARTIS ONCOLOGY

Learn More About Novartis Oncology

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.

 
 

Novartis Oncology

Oncology News is a current news service provided by Doctor's Guide®. Novartis accepts no responsibility for and makes no representations or warranties regarding the content of the information presented.

Ok